Microstructure of Temporomandibular Joint Cartilage after Intra-Articular Betamethasone Sodium Phosphate/Betamethasone Dipropionate Injection during the Early Stage of Experimental Osteoarthrosis
Objective: to study the morphological changes in cartilage after a single intra-articular betamethasone sodium phosphate (BSP)/betamethasone dipropionate (BDP) injection during the early stage of experimental osteoarthrosis (OA) of the temporomandibular joint (TMJ). Material and Methods: The expe...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Medical Research and Development Corporation
2014-06-01
|
| Series: | International Journal of Biomedicine |
| Subjects: | |
| Online Access: | http://ijbm.org/articles/Article4_2_EM1.pdf |
| Summary: | Objective: to study the morphological changes in cartilage after a single intra-articular betamethasone sodium phosphate (BSP)/betamethasone dipropionate (BDP) injection during the early stage of experimental osteoarthrosis (OA) of the temporomandibular joint (TMJ).
Material and Methods: The experiment was performed on 18 male rabbits aged 6 months .The first group consisted of 9 healthy rabbits. The second group included 9 rabbits with mechanically induced TMJ OA. For 5 days, 3 hours daily, a load (with a force of 200N) on the TMJ was imposed. In the left TMJ of the second group of rabbits, betamethasone was injected intra-articularly in different doses: 0.1 ml (n=3), 0.3 ml (n=3), and 0.5 ml (n=3). The right TMJ was used for comparison. A combined anesthesia was applied each experimental day. Rabbits of both groups were sacrificed on days 7, 14, and 30 with introductory combined anesthesia and intravenous injection of Zoletil 100® 20 mg/kg to stop their breathing.
Results: Betamethasone caused destruction of the chondrocytes, fragmentation of collagen fibers, deficit of proteoglycans (PGs) and glycosaminoglycans (GAGs), thinning of the cartilage, and contributed to the progression of TMJ OA.
Conclusion: The optimal dose of BSP/BDP for intra-articular injection in the early stages of TMJ OA must be within the range of 0.1-0.3 ml|0.7-1.5 mg. |
|---|---|
| ISSN: | 2158-0510 2158-0529 |